血液透析机和腹膜透析市场按治疗类型、方式、技术、产品类型、最终用户和患者类型划分－全球预测，2025-2032年

预计到 2032 年，血液透析机和腹膜透析市场规模将达到 1,517.3 亿美元，复合年增长率为 6.78%。

本文简要说明了影响透析治疗服务提供和相关人员优先事项的临床、技术和营运方面的演变因素。

肾衰竭的治疗格局正经历着由技术进步、护理模式转变、人口结构变化和监管政策调整等因素所驱动的重大变革。儘管血液透析机在许多医疗系统中仍然是肾臟替代疗法的基石，但腹膜透析因其以患者为中心的优势（包括患者自主性和减轻医疗机构负担）而重新受到青睐。机器自动化、液体处方和血管通路管理方面的进步不断改进临床实践，而基于价值的支付模式和居家照护奖励也在重塑医疗服务提供者的奖励。

临床医生和营运人员必须平衡当前的临床需求与长期永续性。这需要整合数位化监测以实现个人化治疗，加强供应链协作以减少中断，并重新思考培训计划以扩大居家医疗。同时，製造商正在投资模组化平台、改进透析膜和监测系统，以提高效率、安全性和数据连接性。因此，各方相关人员正在调整策略，以应对不断变化的患者偏好、监管要求和竞争格局，同时保持高标准的临床疗效和营运可靠性。

家庭优先策略、先进医疗设备的应用以及对永续性的需求如何重塑医疗服务模式、医疗服务提供者的优先事项和支付方的奖励

透析领域正经历一场变革性的转变，而这场转变影响着临床路径、治疗地点以及供应商生态系统。家庭透析治疗的日益普及是其中最显着的变化之一，这得益于人体工学设备的改进、远端患者监护技术的进步以及结构化看护者培训计画的完善。向居家照护的转变正在改变透析的使用模式，催生了对小型化、易用型设备的需求，并重新定义了服务模式，更加重视远端支援和物流。

另一个变革性趋势是选择性地采用先进的透析技术，例如线上血液透析滤过和更先进的透析设备遥测技术。这些创新为特定患者群体带来了差异化的临床疗效，并促使支付方和医疗服务提供者重新审视通讯协定和报销模式。同时，对永续性和成本控制的日益重视，推动了更废弃物的浓缩液、在临床适用情况下可重复使用的组件以及全生命週期筹资策略。总而言之，这些变化正促使製造商加快产品差异化，促使医疗服务提供者重塑治疗路径，并促使政策制定者重新评估奖励。

全面评估2025年关税改革如何改变透析价值链的采购、筹资策略和产品设计。

2025年美国关税政策正影响透析价值链各环节的采购决策、供应商网络和成本结构。进口关税和关税主导的监管调整使得筹资策略更加重要，迫使医疗系统和製造商重新评估供应商多元化、近岸外包和库存管理政策。这些变化尤其影响那些传统上在国际供应中扮演核心角色、包含众多组件的产品类型，例如透析设备、监控系统和管路组件。

为应对不断上涨的进口成本和日益复杂的合规流程，许多公司正在加快关键製造流程的本地化进程，重新谈判长期供应商合同，并重新设计产品物料材料清单，以降低关税的影响。供应商则透过重新考虑融资时机，并加强以价值为基础的合约来应对，这些合约会考虑包括物流和关税相关费用在内的总拥有成本。同时，企业的创新策略也受到影响，转向模组化设计和不易受关税影响的替代原料。累积作用，导致商业性模式的重塑，更加强调供应链的透明度和合约的弹性。

精准的细分主导智能，将临床模式、产品属性、终端用户管道和病患群体与优化目标定位的策略要务连结起来

细分市场层面的洞察揭示了不同治疗类型、模式、技术、产品、终端使用者和患者群体之间的差异化动态，有助于制定有针对性的策略方法。基于治疗类型，血液透析机和腹膜透析的比较突显了二者在运作规模和病患体验上的差异。在腹膜透析领域，自动化腹膜透析和持续性非卧床腹膜透析之间的模式差异会影响设备的复杂性、训练强度以及远端监测的需求。基于模式，家庭透析治疗透析和中心透析之间的差异影响着从资金分配到人员配备模式的方方面面，而家庭透析治疗类别又可根据辅助照护和自我护理路径进一步细分。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 整合远端患者监护技术的家用血液透析机系统正日益普及
• 穿戴式人工肾臟装置为末期肾臟病患者提供便携性和持续透析。
• 永续透析液回收和水净化创新技术，以减少透析中心的资源消耗
• 整合人工智慧驱动的预测分析，以优化透析治疗方案和个人化护理计划
• 有利的政府报销政策推动了新兴市场腹膜透析的扩张。
• 开发生物相容性透析膜，以最大限度减少发炎反应并改善患者预后。
• 可携式腹膜透析週期计可提高患者在各种护理环境中的活动能力和独立性。
• 远端医疗的病人参与平台可提高家庭透析治疗治疗的依从性和疗效。
• 策略性医疗器材和生物製药合作，开发针对末期肾病併发症的新治疗方法
• 符合环保法规并排放医疗废弃物的环保一次性透析产品

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按治疗类型分類的血液透析机和腹膜透析市场

• 血液透析机
• 腹膜透析
  • 自动腹膜透析
  • 持续性携带式腹膜透析

第九章血液透析机/腹膜透析市场：依透析方式划分

• 家
  • 辅助护理
  • 自我治疗
• 中心内部

第十章 按技术分類的血液透析机和腹膜透析市场

• 传统血液透析机
• 线上血液透析机
  • 混合流
  • 替代流

第十一章 依产品类型分類的血液透析机和腹膜透析市场

• 浓缩液
• 透析设备
• 透析器
  • 高通量
  • 低通量
• 监控系统
• 管组

第十二章 依最终用户分類的血液透析机和腹膜透析市场

• 透析中心
• 居家照护机构
• 医院
• 专科诊所

第十三章 依病患类型分類的血液透析机和腹膜透析市场

• 成人
• 老年人
• 孩子们

第十四章 按地区分類的血液透析机和腹膜透析市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十五章 按组别分類的血液透析机和腹膜透析市场

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十六章 各国血液透析机及腹膜透析市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十七章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Nipro Corporation
  • Toray Industries, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Diaverum AB
  • Jafron Biomedical Co., Ltd.
  • NxStage Medical, Inc.

The Hemodialysis & Peritoneal Dialysis Market is projected to grow by USD 151.73 billion at a CAGR of 6.78% by 2032.

A concise orientation to the evolving clinical, technological, and operational forces reshaping dialysis care delivery and stakeholder priorities

The treatment landscape for kidney failure is undergoing a meaningful evolution driven by technology, shifting care models, demographic pressures, and regulatory recalibrations. Hemodialysis remains a cornerstone of renal replacement therapy delivery in many health systems, while peritoneal dialysis is gaining renewed attention because of patient-centric advantages such as autonomy and reduced facility burden. Advances in machine automation, fluid formulations, and vascular access management continue to refine clinical practice, even as value-based payment models and home-care incentives reshape provider incentives.

Clinicians and operators must balance acute clinical imperatives with long-term sustainability. This means integrating digital monitoring to personalize therapy, strengthening supply chain partnerships to mitigate disruption, and rethinking training programs to scale home-based modalities. At the same time, manufacturers are investing in modular platforms, improved dialyzer membranes, and monitoring systems that enhance efficiency, safety, and data connectivity. As a result, stakeholders across the continuum are retooling strategies to meet changing patient preferences, regulatory expectations, and competitive dynamics, while preserving high standards of clinical effectiveness and operational reliability.

How home-first strategies, advanced device adoption, and sustainability imperatives are jointly rewriting care delivery models, supplier priorities, and payer incentives

The dialysis landscape is experiencing transformative shifts that affect clinical pathways, care delivery locations, and supplier ecosystems. Increasing acceptance of home modalities is one of the most consequential changes, supported by improvements in device ergonomics, remote patient monitoring, and structured caregiver training programs. This migration toward home-based care alters utilization patterns, creates demand for compact, user-friendly devices, and redefines service models to emphasize remote support and logistics.

Another transformative trend is the selective adoption of advanced dialysis technologies such as online hemodiafiltration and more sophisticated dialysis machine telemetry. These innovations are introducing differentiated clinical outcomes for specific patient cohorts and prompting payers and providers to consider revised protocols and reimbursement models. Concurrently, there is intensified focus on sustainability and cost containment, encouraging adoption of low-waste concentrates, reusable components where clinically appropriate, and lifecycle procurement strategies. Collectively, these shifts are prompting manufacturers to accelerate product differentiation, providers to reconfigure care pathways, and policymakers to revisit regulations and incentives that influence where and how dialysis care is delivered.

An integrated assessment of how tariff changes enacted in 2025 have reshaped procurement, sourcing strategy, and product design across the dialysis value chain

The tariff landscape introduced in the United States in 2025 has influenced procurement decisions, supplier networks, and cost structures across the dialysis value chain. Import duties and tariff-driven regulatory adjustments have contributed to increased attention on sourcing strategies, prompting health systems and manufacturers to re-evaluate supplier diversification, nearshoring, and inventory management policies. These shifts have had particular resonance for component-heavy product categories such as dialysis machines, monitoring systems, and tubing sets where international supply streams historically play a central role.

As organizations adjust to elevated import costs and compliance complexity, many have accelerated efforts to localize key manufacturing steps, renegotiate long-term supplier agreements, and redesign product bill-of-materials to reduce tariff exposure. Providers have responded by reassessing capital procurement timing and by intensifying value-based contracting conversations that account for total cost of ownership, including logistics and tariff-related expenses. Simultaneously, innovation strategies have been influenced as companies target modular designs and alternative raw materials to limit tariff sensitivity. The cumulative effect is a reconfiguration of commercial playbooks and an increased premium on supply chain transparency and contractual resilience.

Precise segmentation-driven intelligence linking clinical modality, product characteristics, end-user channels, and patient cohorts to strategic imperatives for optimized targeting

Segment-level insights reveal differentiated dynamics across treatment type, modality, technology, product, end-user, and patient cohorts that inform targeted strategic approaches. Based on Treatment Type, the comparative trajectories of Hemodialysis and Peritoneal Dialysis highlight contrasting operational footprints and patient experience profiles; within Peritoneal Dialysis, the distinctions between Automated Peritoneal and Continuous Ambulatory Peritoneal modalities influence device complexity, training intensity, and remote-monitoring needs. Based on Modality, the home versus in-center divide frames everything from capital allocation to staffing models, with the Home category further differentiated by Assisted Care and Self Care pathways that carry distinct clinical governance and reimbursement implications.

Based on Technology, the split between Conventional Hemodialysis and Online Hemodiafiltration underscores differing clinical evidence bases and infrastructure requirements, while the latter's Mixed Flow and Substitution Flow variants create nuanced clinical and capital considerations for adoption. Based on Product Type, categories such as Concentrates Fluids, Dialysis Machines, Dialyzers, Monitoring Systems, and Tubing Sets each follow separate innovation and regulatory timelines, and within Dialyzers the High Flux and Low Flux subtypes carry implications for therapy customization and supply inventory planning. Based on End User, distribution and service models vary significantly among Dialysis Centers, Home Care Settings, Hospitals, and Specialty Clinics, shaping commercial channels and aftermarket services. Based on Patient Type, distinct clinical pathways and device configurations are required for Adult, Geriatric, and Pediatric populations, affecting training protocols, dosing algorithms, and caregiver supports. Taken together, these segmentation lenses permit granular prioritization of investments, tailored go-to-market tactics, and differentiated clinical support programs that align with both patient needs and organizational capabilities.

How regional healthcare structures, reimbursement diversity, and supply chain realities are shaping differentiated adoption paths and go-to-market priorities globally

Regional dynamics continue to exert a defining influence on technology adoption, reimbursement mechanisms, and operational models across dialysis care. In the Americas, health system consolidation, established dialysis provider networks, and policy emphasis on value-based care drive demand for scalable in-center efficiency tools and a growing interest in home dialysis models that reduce facility burden. In contrast, Europe, Middle East & Africa present a mosaic of reimbursement environments and regulatory frameworks that influence adoption cadence for advanced technologies, with pockets of rapid uptake in markets that prioritize chronic disease management and remote care infrastructure.

Asia-Pacific encompasses a range of healthcare maturity levels, from advanced systems investing in digital health and localized manufacturing to emerging markets where access, affordability, and workforce constraints limit rapid modality transitions. Across regions, supply chain strategies, tariff exposure, and local manufacturing incentives influence product availability and pricing dynamics. The practical implication is that manufacturers and providers must calibrate regional go-to-market strategies, regulatory engagement, and service delivery models to the specific reimbursement incentives, infrastructure readiness, and patient population characteristics of each geography.

Competitive behaviors and strategic investments reveal a clear pivot toward integrated product-service platforms, clinical evidence generation, and regional capability expansion

Leading companies in the dialysis ecosystem are pursuing a mix of clinical differentiation, platform consolidation, and service-based models to sustain growth and defend margins. Product innovation focuses on smaller, more intuitive home devices, advanced dialyzer materials that improve biocompatibility and clearance, and integrated monitoring systems that enable remote titration of therapy and earlier intervention. Companies are also expanding service portfolios to include training programs, logistics management, and outcomes-based partnerships with providers, reflecting recognition that durable value often lies in the interplay between device performance and continuous clinical support.

Strategic alliances and selective acquisitions remain active pathways to accelerate capability-building, particularly in digital health, disposables manufacturing, and regional distribution. Firms are investing in real-world evidence generation to support differentiated clinical claims and payer negotiations, while also optimizing aftermarket service and consumables revenue streams. The competitive landscape rewards organizations that can combine robust clinical data, regulatory agility, and operational excellence to deliver seamless patient journeys across in-center and home settings.

Actionable strategic priorities for manufacturers, providers, payers, and supply chain leaders to strengthen resilience and accelerate modality transitions

Industry leaders should prioritize a set of targeted actions to navigate current headwinds and capture emerging opportunities across the dialysis continuum. Manufacturers ought to accelerate modular design initiatives that reduce reliance on tariff-sensitive components and simplify field servicing, while simultaneously enhancing digital telemetry to support remote monitoring and predictive maintenance. Providers should expand home modality programs through rigorous training curriculums, caregiver support frameworks, and partnership-based care pathways that lower barriers to patient uptake. Payers and policymakers can meaningfully influence adoption by calibrating reimbursement policies to reward outcomes and enable scalable home care delivery.

Supply chain leaders should pursue supplier diversification and nearshoring where feasible to reduce exposure to tariff volatility and logistical bottlenecks, and should increase investments in inventory analytics to balance cost and clinical readiness. Commercial teams must refine value propositions that articulate total cost of care and clinical outcomes rather than focusing on unit price alone, thereby enabling longer-term contracting that absorbs short-term tariff fluctuations. Finally, all stakeholders should commit to robust data governance and interoperability standards to ensure patient safety, facilitate remote care, and accelerate evidence generation that supports appropriate therapy selection.

A transparent synthesis of secondary evidence, targeted primary interviews, and rigorous data triangulation to ensure credible and actionable insights

The research underpinning this report combines systematic secondary review with structured primary engagement to ensure balanced, verifiable insights. The secondary phase incorporated peer-reviewed clinical literature, regulatory filings, device technical specifications, and policy documents to establish a baseline understanding of clinical practice and technology performance. This foundation was augmented by primary interviews with a cross-section of stakeholders including clinicians, procurement leaders, device engineers, and payers to validate trends, capture operational realities, and surface emerging commercial behaviors.

Data triangulation techniques were applied to reconcile discrepancies between reported performance claims, regulatory documentation, and frontline user experiences. Segmentation frameworks were iteratively refined to reflect clinically meaningful distinctions across treatment type, modality, technology, product, end-user, and patient cohorts. Limitations are acknowledged with transparency: where evidence was sparse, findings were flagged as emergent and recommendations were framed to accommodate scenario-based planning. Ethical considerations guided respondent confidentiality and conflict-of-interest screening during primary engagement to preserve the integrity of conclusions.

A definitive synthesis of clinical, technological, and commercial signals that highlights decisive pathways to sustainable growth and improved patient outcomes

The dialysis sector stands at an inflection point characterized by converging technological innovation, shifting care delivery models, and heightened operational complexity. Home modalities, fueled by device miniaturization and remote monitoring, present a compelling alternative to facility-centric care for many patients, while advanced therapies and materials are refining clinical capabilities for selected cohorts. At the same time, policy changes and tariff dynamics are reshaping procurement and manufacturing priorities, compelling stakeholders to adopt more resilient, agile strategies.

Looking ahead, organizations that invest in integrated product-service offerings, strengthen regional supply chain resilience, and generate robust real-world evidence are positioned to lead. Collaboration among manufacturers, providers, payers, and regulators will be essential to harmonize incentives and accelerate adoption of care models that improve patient experience while containing system costs. In short, success will depend on the ability to translate emerging clinical and technological promise into scalable, economically viable care pathways that meet the needs of diverse patient populations.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rising adoption of home-based hemodialysis systems integrated with remote patient monitoring technologies
• 5.2. Wearable artificial kidney devices advancing portability and continuous dialysis for end-stage renal disease patients
• 5.3. Sustainable dialysate recycling and water purification innovations to reduce resource consumption in dialysis centers
• 5.4. Integration of AI-driven predictive analytics to optimize dialysis treatment schedules and personalized care plans
• 5.5. Expansion of peritoneal dialysis in emerging markets driven by favorable government reimbursement policies
• 5.6. Development of biocompatible dialysis membranes minimizing inflammatory responses and improving patient outcomes
• 5.7. Portable peritoneal dialysis cyclers enhancing patient mobility and independence across diverse care settings
• 5.8. Telehealth-enabled patient engagement platforms improving adherence and outcomes in home-based dialysis therapies
• 5.9. Strategic device and biopharma partnerships for developing novel therapies targeting end-stage kidney disease complications
• 5.10. Eco-friendly single-use dialysis products addressing environmental regulations and reducing medical waste footprint

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hemodialysis & Peritoneal Dialysis Market, by Treatment Type

• 8.1. Hemodialysis
• 8.2. Peritoneal Dialysis
  • 8.2.1. Automated Peritoneal
  • 8.2.2. Continuous Ambulatory Peritoneal

9. Hemodialysis & Peritoneal Dialysis Market, by Modality

• 9.1. Home
  • 9.1.1. Assisted Care
  • 9.1.2. Self Care
• 9.2. In Center

10. Hemodialysis & Peritoneal Dialysis Market, by Technology

• 10.1. Conventional Hemodialysis
• 10.2. Online Hemodiafiltration
  • 10.2.1. Mixed Flow
  • 10.2.2. Substitution Flow

11. Hemodialysis & Peritoneal Dialysis Market, by Product Type

• 11.1. Concentrates Fluids
• 11.2. Dialysis Machines
• 11.3. Dialyzers
  • 11.3.1. High Flux
  • 11.3.2. Low Flux
• 11.4. Monitoring Systems
• 11.5. Tubing Sets

12. Hemodialysis & Peritoneal Dialysis Market, by End User

• 12.1. Dialysis Centers
• 12.2. Home Care Settings
• 12.3. Hospitals
• 12.4. Specialty Clinics

13. Hemodialysis & Peritoneal Dialysis Market, by Patient Type

• 13.1. Adult
• 13.2. Geriatric
• 13.3. Pediatric

14. Hemodialysis & Peritoneal Dialysis Market, by Region

• 14.1. Americas
  • 14.1.1. North America
  • 14.1.2. Latin America
• 14.2. Europe, Middle East & Africa
  • 14.2.1. Europe
  • 14.2.2. Middle East
  • 14.2.3. Africa
• 14.3. Asia-Pacific

15. Hemodialysis & Peritoneal Dialysis Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Hemodialysis & Peritoneal Dialysis Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Share Analysis, 2024
• 17.2. FPNV Positioning Matrix, 2024
• 17.3. Competitive Analysis
  • 17.3.1. Fresenius Medical Care AG & Co. KGaA
  • 17.3.2. DaVita Inc.
  • 17.3.3. B. Braun Melsungen AG
  • 17.3.4. Baxter International Inc.
  • 17.3.5. Nipro Corporation
  • 17.3.6. Toray Industries, Inc.
  • 17.3.7. Asahi Kasei Medical Co., Ltd.
  • 17.3.8. Diaverum AB
  • 17.3.9. Jafron Biomedical Co., Ltd.
  • 17.3.10. NxStage Medical, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 32. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY REGION, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY REGION, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY REGION, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY REGION, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY REGION, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY REGION, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 183. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 184. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 185. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 186. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 187. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 188. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 189. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 190. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 191. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 192. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 193. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 194. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 195. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 196. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 197. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 198. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 199. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 200. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 201. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 202. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 203. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 204. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 205. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 207. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 208. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 209. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 210. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 211. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 212. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 213. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 214. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 215. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 216. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 217. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 218. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 219. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 220. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 221. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 222. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 223. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 224. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 225. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 226. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 227. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 228. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 229. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 230. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 231. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 232. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 233. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 234. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 235. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 236. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 237. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 238. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 239. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 240. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 241. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 242. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 243. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 244. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 245. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 246. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 247. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 248. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 270. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 271. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 272. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 273. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 274. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 275. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 276. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 277. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 278. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 279. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 280. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 281. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 282. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (US